Drug intelligence / Profile preview

naganishia albida lysate

Development stage: Unknown

Overview

No specific information regarding 'naganishia albida lysate' was found in the provided context. The context discusses lysates from other yeast strains, specifically Rhodotorula mucilaginosa and Cryptococcus laurentii, which were isolated from human breast milk and evaluated for their anti-colon cancer effects and probiotic potential. These other yeast lysates demonstrated inhibition of colon cancer cell proliferation and induction of apoptosis and autophagy.

Beyond the preview

Go deeper on naganishia albida lysate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on naganishia albida lysate.

Explore the full profile